A case of overlap between eosinophilic fasciitis and generalized morphea
Accepted: 9 August 2023
HTML: 6
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Dear Editor,
Eosinophilic fasciitis is a rare connective tissue disease that presents as a cutaneous edema and skin sclerosis of the distal extremities [...]
Wlodek C, Korendowych E, McHugh N, Lovell CR. Morphoea profunda and its relationship to eosinophilic fasciitis. Clin Exp Dermatol 2018;43:306–10 DOI: https://doi.org/10.1111/ced.13353
Onajin O, Wieland CN, Peters MS, Lohse CM, Lehman JS. Clinicopathologic and immunophenotypic features of eosinophilic fasciitis and morphea profunda: A comparative study of 27 cases. J Am Acad Dermatol 2018;78:121–8. DOI: https://doi.org/10.1016/j.jaad.2017.06.148
Mertens JS, Seyger MMB, Thurlings RM, Radstake T, de Jong E. Morphea and eosinophilic fasciitis: An update. Am J Clin Dermatol 2017;18:491–512. DOI: https://doi.org/10.1007/s40257-017-0269-x
Alexanian C, Cheng M, Kiuru M, Wang JZ, Le ST, Tartar DM. Eosinophilic fasciitis presenting as a unilateral, solitary plaque. Dermatol Online J. 2019;25:8 DOI: https://doi.org/10.5070/D3258045130
Watanabe Y, Yamamoto M, Yamamoto T. A case of eosinophilic fasciitis and generalized morphea overlap. Dermatol Online J. 2020;26:2 DOI: https://doi.org/10.5070/D3262047425
Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB. Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17:221–31. DOI: https://doi.org/10.1016/0049-0172(88)90008-X
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.